Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

29.56 +0.15 (+0.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,215,227
Open 29.53
Bid (Size) 29.22 (300)
Ask (Size) 29.45 (500)
Prev. Close 29.41
Today's Range 28.01 - 29.66
52wk Range 18.92 - 43.15
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Smartest Growth Stock to Buy With $30 Right Now ↗
This pre-revenue biopharmaceutical stock is a home run swing worth taking. 
Via The Motley Fool
VKTX Shares Garner Retail Attention Ahead Of Q4 Earnings Report ↗
Via Stocktwits

Performance

YTD
-16.5%
-16.5%
1 Month
-8.0%
-8.0%
3 Month
-18.9%
-18.9%
6 Month
-7.3%
-7.3%
1 Year
-8.7%
-8.7%

More News

Read More
News headline image
2 Biotech Stocks Set to Rebound in 2026 ↗
Via The Motley Fool
News headline image
Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker? ↗
Via The Motley Fool
News headline image
3 Growth Stocks to Invest $1,000 in Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals ↗
Via Stocktwits
News headline image
The Best Stocks to Invest $40 in to Start the New Year Off Right ↗
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the Obesity Duopoly
Via Finterra
Topics Intellectual Property
News headline image
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 ↗
Via The Motley Fool
News headline image
The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era
Via MarketMinute
Topics Economy
News headline image
2 Bargain Stocks You Can Buy for Less Than $100 Right Now ↗
Via The Motley Fool
News headline image
1 Stock That Could Soar by 175%, According to Wall Street ↗
Via The Motley Fool
News headline image
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗
Via The Motley Fool
News headline image
3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 ↗
Via MarketBeat
News headline image
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
Via MarketBeat
Topics ETFs
News headline image
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
Via Finterra
Topics Economy
News headline image
The Great Rotation: Small-Caps Log Longest Winning Streak Against S&P 500 Since 2019
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
What Investors Should Know About a Viking Therapeutics Insider's $2 Million Stock Sale ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)
Via PredictStreet
Topics Earnings Economy Intellectual Property
News headline image
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Trillion-Dollar Treatment: Eli Lilly Solidifies Dominance as Obesity Drug Boom Enters New Era
Via MarketMinute
Topics Economy
News headline image
Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
The Trillion-Dollar Pivot: Eli Lilly Unleashes Volume-Led Strategy to Cement Obesity Market Dominance in 2026
Via MarketMinute
Topics Economy
News headline image
The Great 2026 Pivot: Tech and Healthcare Surge as Broader Market Rally Hits a Wall
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Viking Therapeutics Stock Suffers Worst Day In Over 4 Months As Top Execs Dump Shares — Novo’s $149 Wegovy Move Looms ↗
Via Stocktwits

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 29.56
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 02/04/26 04:00 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.94B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.